ArticleBMC biotechnology2019

Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies.

Marie-Claire Devilder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.